Jennifer Hudson has delighted fans with an exciting new update, and it’s all about the moment-making Spirit Tunnel that has ...

Taylor Swift is a self-made billionaire, but she has a long history of generosity when it comes to her money. One recent story highlights that. During an appearance on “The Jennifer Hudson Show” this ...

Many times, your favorite stars are seen wearing the same outfit on the red carpet, in photo spreads, during interviews, and ...

Once a pillar of Canadian retail, Hudson’s Bay is nearing the end of its illustrious 355-year journey, amidst unprecedented liquidation plans impacting numerous stores nationwide. The news has sent ...

The recent increase in volatility is a unique test for these investments, since many of these covered-call funds came to market after 2020 and the broader sell-off during Covid. QDTE has offered ...

Clene planning to submit a New Drug Application (NDA) in the second half of 2025 for potential Accelerated Approval of CNM-Au8® in ALS Clene planning to initiate the confirmatory Phase 3 RESTORE ...

Fourth Quarter 2024 and Recent Highlights Positive Phase 1b interim data released for ABI-4334, a next-generation highly potent capsid assembly modulator candidate for chronic HBV (cHBV ...

BOISE, Idaho, March 20, 2025 /PRNewswire/ - Perpetua Resources Corp. (NASDAQ: PPTA) (TSX: PPTA) ("Perpetua Resources" or "Perpetua" or the "Company"), announced today ...

Published 2023 Sustainability Report, the Company's eleventh annual sustainability report. Appointed mining industry veteran Jonathan Cherry as new President and CEO, and as a Director. Awarded ...

RICHMOND, Va. — A new exhibit at the Virginia Museum of History and Culture (VMHC) explores the Commonwealth’s important role in the American Revolution, according to museum leaders.

Jennifer paired the look with her favorite shoes ... Most recently, Amal Clooney was spotted in New York City accompanying her husband George Clooney, who is making his Broadway debut in the ...

and recent highlights. “We are well-positioned to deliver important clinical data on four of our novel antiviral candidates in 2025, including proof-of-concept efficacy data expected this fall ...